These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12949021)

  • 1. Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy.
    Stauffer BL; Hoetzer GL; Smith DT; DeSouza CA
    J Appl Physiol (1985); 2004 Jan; 96(1):143-8. PubMed ID: 12949021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibrinogen levels in healthy postmenopausal women: physical activity and hormone replacement status.
    DeSouza CA; Stevenson ET; Davy KP; Jones PP; Seals DR
    J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M294-8. PubMed ID: 9310083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.
    Vitale C; Gebara O; Mercuro G; Wajngarten M; Silvestri A; Rossini P; Ramires JA; Fini M; Rosano GM
    Maturitas; 2005 Apr; 50(4):239-46. PubMed ID: 15780522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement.
    Manns PJ; Williams DP; Snow CM; Wander RC
    Am J Hum Biol; 2003; 15(1):91-100. PubMed ID: 12552583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total blood volume in endurance-trained postmenopausal females: relation to exercise mode and maximal aerobic capacity.
    Parker Jones P; Davy KP; Desouza CA; Tanaka H
    Acta Physiol Scand; 1999 Aug; 166(4):327-33. PubMed ID: 10468670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
    Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
    Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity, hormone replacement therapy and plasma lipoprotein-lipid levels in postmenopausal women.
    Hagberg JM; McCole SD; Ferrell RE; Zmuda JM; Rodgers KS; Wilund KR; Moore GE
    Int J Sports Med; 2003 Jan; 24(1):22-9. PubMed ID: 12582948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
    JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women.
    Moreau KL; Donato AJ; Seals DR; DeSouza CA; Tanaka H
    Cardiovasc Res; 2003 Mar; 57(3):861-8. PubMed ID: 12618248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
    D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
    Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regular exercise and the age-related decline in resting metabolic rate in women.
    Van Pelt RE; Jones PP; Davy KP; Desouza CA; Tanaka H; Davy BM; Seals DR
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3208-12. PubMed ID: 9329340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
    Caserta L; Caserta R; Torella M; Perricone F; Nesti E; Sessa M; Tagliaferri A; De Francesco F; De Lucia D; Panariello S
    Minerva Ginecol; 2004 Apr; 56(2):131-6. PubMed ID: 15258541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic hemodynamic determinants of blood pressure in women: age, physical activity, and hormone replacement.
    Hunt BE; Davy KP; Jones PP; DeSouza CA; Van Pelt RE; Tanaka H; Seals DR
    Am J Physiol; 1997 Aug; 273(2 Pt 2):H777-85. PubMed ID: 9277495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
    Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
    Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
    Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
    Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
    Lakoski SG; Herrington DM
    Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular hemodynamics with increasing exercise intensities in postmenopausal women.
    McCole SD; Brown MD; Moore GE; Zmuda JM; Cwynar JD; Hagberg JM
    J Appl Physiol (1985); 1999 Dec; 87(6):2334-40. PubMed ID: 10601186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Habitual aerobic exercise is associated with smaller femoral artery intima-media thickness with age in healthy men and women.
    Moreau KL; Silver AE; Dinenno FA; Seals DR
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):805-11. PubMed ID: 17001222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal and submaximal aerobic fitness in postmenopausal women: influence of hormone-replacement therapy.
    Stathokostas L; Kowalchuk JM; Petrella RJ; Paterson DH
    Appl Physiol Nutr Metab; 2008 Oct; 33(5):922-8. PubMed ID: 18923567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.